EEG-triggered fMRI in Epilepsy Patients

Baptist Health South Florida1 site in 1 country2 target enrollmentFebruary 1, 2013

ConditionsEpilepsy

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Epilepsy
Sponsor: Baptist Health South Florida
Enrollment: 2
Locations: 1
Primary Endpoint: Number of participants with at least 40 interictal epileptic discharges during the fMRI
Status: Completed
Last Updated: 6 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

A prospective exploratory study in patients with drug resistant epilepsy with a target comparison of long term outcome. NeuroScan software modules and a MagLink will be used to acquire EEG in combination with MRI/fMRI data. The MagLink system is used for obtaining integrated EEG and Event Related Potential (ERP) recordings while the subject is inside the MRI machine, without compromising the raw EEG data.

Registry

clinicaltrials.gov

Start Date

February 1, 2013

End Date

July 30, 2019

Last Updated

6 years ago

Study Type

Interventional

Study Design

Single Group

Sex

All

Investigators

Sponsor

Baptist Health South Florida

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Refractory epilepsy cases, referred by the service of Neurology. These are cases whose pathophysiology is resistant to treatment, including change in medication and or added medication.
•Patients will be included if they agree to sign an Institutional Review Board approved written consent.

Exclusion Criteria

•Patients with overt symptoms or signs of anxiety than cannot cooperate during the recording inside the scanner, unless consent is given for the procedure to be performed with sedation by the anesthesia department.
•Patients who meet the regular exclusion criteria for Magnetic Resonance Imaging (MRI) studies per the prescreening form reviewed with all patients prior to exams